BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

732 related articles for article (PubMed ID: 1933236)

  • 1. Cognitive impairment in early, untreated Parkinson's disease and its relationship to motor disability.
    Cooper JA; Sagar HJ; Jordan N; Harvey NS; Sullivan EV
    Brain; 1991 Oct; 114 ( Pt 5)():2095-122. PubMed ID: 1933236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive impairment in Parkinson's disease: more than a frontostriatal dysfunction.
    Galtier I; Nieto A; Lorenzo JN; Barroso J
    Span J Psychol; 2014 Oct; 17():E68. PubMed ID: 26054917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cognitive impairment in Parkinson's disease].
    Tachibana H
    Seishin Shinkeigaku Zasshi; 2013; 115(11):1142-9. PubMed ID: 24450147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychological impairment in Parkinson's disease with and without depression.
    Tröster AI; Stalp LD; Paolo AM; Fields JA; Koller WC
    Arch Neurol; 1995 Dec; 52(12):1164-9. PubMed ID: 7492290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different effects of dopaminergic and anticholinergic therapies on cognitive and motor function in Parkinson's disease. A follow-up study of untreated patients.
    Cooper JA; Sagar HJ; Doherty SM; Jordan N; Tidswell P; Sullivan EV
    Brain; 1992 Dec; 115 ( Pt 6)():1701-25. PubMed ID: 1486457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of vascular risk factors on cognitive function in early Parkinson's disease.
    Doiron M; Langlois M; Dupré N; Simard M
    Int J Geriatr Psychiatry; 2018 Feb; 33(2):288-297. PubMed ID: 28509343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive and motor functioning in Parkinson disease: subjects with and without questionable dementia.
    Goldman WP; Baty JD; Buckles VD; Sahrmann S; Morris JC
    Arch Neurol; 1998 May; 55(5):674-80. PubMed ID: 9605724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive impairment in early-stage non-demented Parkinson's disease patients.
    Pfeiffer HC; Løkkegaard A; Zoetmulder M; Friberg L; Werdelin L
    Acta Neurol Scand; 2014 May; 129(5):307-18. PubMed ID: 24117192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visual dysfunction in Parkinson disease without dementia.
    Uc EY; Rizzo M; Anderson SW; Qian S; Rodnitzky RL; Dawson JD
    Neurology; 2005 Dec; 65(12):1907-13. PubMed ID: 16282276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. State anxiety predicts cognitive performance in patients with Parkinson's disease.
    Ehgoetz Martens KA; Silveira CRA; Intzandt BN; Almeida QJ
    Neuropsychology; 2018 Nov; 32(8):950-957. PubMed ID: 30284873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between motor symptom lateralization and cognitive performance in newly diagnosed drug-naïve patients with Parkinson's disease.
    Poletti M; Frosini D; Pagni C; Baldacci F; Giuntini M; Mazzucchi S; Tognoni G; Lucetti C; Del Dotto P; Ceravolo R; Bonuccelli U
    J Clin Exp Neuropsychol; 2013; 35(2):124-31. PubMed ID: 23216295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deficit in specific cognitive domains associated with dementia in Parkinson's disease.
    Pal A; Pegwal N; Kaur S; Mehta N; Behari M; Sharma R
    J Clin Neurosci; 2018 Nov; 57():116-120. PubMed ID: 30150061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association of cognitive reserve with motor and cognitive functions for different stages of Parkinson's disease.
    Guzzetti S; Mancini F; Caporali A; Manfredi L; Daini R
    Exp Gerontol; 2019 Jan; 115():79-87. PubMed ID: 30502539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive performance in nondemented nonpsychotic Parkinson disease patients with or without a history of depression prior to the onset of motor symptoms.
    Klepac N; Hajnsek S; Trkulja V
    J Geriatr Psychiatry Neurol; 2010 Mar; 23(1):15-26. PubMed ID: 19996416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CERAD test performance and cognitive impairment in Parkinson's disease.
    Karrasch M; Laatu S; Martikainen K; Marttila R
    Acta Neurol Scand; 2013 Dec; 128(6):409-13. PubMed ID: 23668316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive performance in multiple system atrophy.
    Robbins TW; James M; Lange KW; Owen AM; Quinn NP; Marsden CD
    Brain; 1992 Feb; 115 Pt 1():271-91. PubMed ID: 1559159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paradoxical effect of dopamine medication on cognition in Parkinson's disease: relationship to side of motor onset.
    Hanna-Pladdy B; Pahwa R; Lyons KE
    J Int Neuropsychol Soc; 2015 Apr; 21(4):259-70. PubMed ID: 25923830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploratory analysis of neuropsychological and neuroanatomical correlates of progressive mild cognitive impairment in Parkinson's disease.
    Lee JE; Cho KH; Song SK; Kim HJ; Lee HS; Sohn YH; Lee PH
    J Neurol Neurosurg Psychiatry; 2014 Jan; 85(1):7-16. PubMed ID: 23828835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The roles of sequencing and verbal working memory in sentence comprehension deficits in Parkinson's disease.
    Hochstadt J; Nakano H; Lieberman P; Friedman J
    Brain Lang; 2006 Jun; 97(3):243-57. PubMed ID: 16332387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Marked brain asymmetry with intact cognitive functioning in idiopathic Parkinson's disease: a longitudinal analysis.
    Tanner JJ; Levy SA; Schwab NA; Hizel LP; Nguyen PT; Okun MS; Price CC
    Clin Neuropsychol; 2017 Apr; 31(3):654-675. PubMed ID: 27813459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.